Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Rezolute Inc
(NQ:
RZLT
)
4.350
+0.100 (+2.35%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Rezolute Inc
< Previous
1
2
Next >
Rezolute Announces Initiation of a Phase 2 Study of RZ402 in Patients with Diabetic Macular Edema
December 15, 2022
RZ402 is an oral therapy being developed as a potential alternative to invasive and suboptimal injections into the eye
From
Rezolute, Inc.
Via
GlobeNewswire
Rezolute Reports First Quarter Fiscal 2023 Results and Highlights Company Progress
November 09, 2022
From
Rezolute, Inc.
Via
GlobeNewswire
Rezolute to Present at the Jefferies London Healthcare Conference
November 01, 2022
From
Rezolute, Inc.
Via
GlobeNewswire
Rezolute Announces Presentation at The Retina Society 55th Annual Scientific Meeting
October 20, 2022
From
Rezolute, Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Rezolute Inc. (NASDAQ: RZLT) Announces Underwritten Public Offering, Concurrent Registered Direct Offering
November 01, 2021
Via
Investor Brand Network
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.